Jinbin Chen

18PUBLICATIONS
20CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 01, 2026
HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study.

|Aug 11, 2025
Social Support, Quality of Life, and Financial Toxicity Among Patients with Hepatocellular Carcinoma.

Shuyue Liu, Yawen Xie, Tiantian Li

|Feb 04, 2025
Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma.

Yao-Jun Zhang, Jinbin Chen, Zhongguo Zhou

|Oct 31, 2024
The Efficacy and Safety of Bevacizumab Plus Anti-PD-1/PD-L1 Inhibitors in Combination with Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma.

Xiang Tang, Jinbin Chen, Wei Peng

|Mar 11, 2024
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.

Wenxuan Li, Zhikai Zheng, Jiongliang Wang

|Dec 07, 2023
Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy.

Tianqing Wu, Zhikai Zheng, Jiongliang Wang

Pageof 3

Frequent Collaborators

16 joint publications

Yaojun Zhang

11 joint publications

Yangxun Pan

9 joint publications

Li Xu

6 joint publications

Zhongguo Zhou